Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04937907
What this trial is testing

Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)

Who this might be right for
Alport Syndrome, X-Linked
Shanghai Children's Hospital 50
Not applicableLooking for participantsNCT06526741
What this trial is testing

ASF Alport Patient Registry

Who this might be right for
Alport SyndromeThin Basement Membrane DiseaseHereditary Nephritis
Alport Syndrome Foundation 2,500
Early research (Phase 1)Study completedNCT03373786
What this trial is testing

RG-012 in Subjects With Alport Syndrome

Who this might be right for
Alport Syndrome
Genzyme, a Sanofi Company 4
Large-scale testing (Phase 3)Ended earlyNCT03749447
What this trial is testing

An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)

Who this might be right for
Chronic Kidney DiseasesAlport SyndromeAutosomal Dominant Polycystic Kidney
Biogen 270
Not applicableStudy completedNCT04689074
What this trial is testing

Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney Diseases

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)Advanced-Chronic Kidney Disease (CKD)Diabetic Kidney Disease (DKD)+1 more
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 150
Testing effectiveness (Phase 2)Study completedNCT03366337
What this trial is testing

Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX

Who this might be right for
IgA NephropathyCKD Associated With Type 1 DiabetesFocal Segmental Glomerulosclerosis+1 more
Biogen 103
Not applicableLooking for participantsNCT05996731
What this trial is testing

Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases

Who this might be right for
Atypical Hemolytic Uremic SyndromeMembranoproliferative GlomerulonephritisAutosomal Dominant Polycystic Kidney+1 more
Mario Negri Institute for Pharmacological Research 105
Not applicableStudy completedNCT00481130
What this trial is testing

Alport Syndrome Treatments and Outcomes Registry

Who this might be right for
Alport Syndrome
University of Minnesota 655
Not applicableLooking for participantsNCT07575347
What this trial is testing

Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)

Who this might be right for
Periodontal DiseasePeriodontitisCKD+6 more
Stefan Lujinschi 100
Post-approval studies (Phase 4)UnknownNCT01184599
What this trial is testing

A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGAHypertension
Kagawa University 30
Not applicableActive Not RecruitingNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableStudy completedNCT01312727
What this trial is testing

Hereditary Tubulointerstitial Nephritis

Who this might be right for
Nephritis, InterstitialChronic Renal FailureGout+1 more
Assistance Publique - Hôpitaux de Paris 225
Not applicableEnded earlyNCT02718027
What this trial is testing

Biomarker for Alport Syndrome (BioAlport)

Who this might be right for
Nephritis, HereditaryHematuria-Nephropathy-Deafness Syndrome
CENTOGENE GmbH Rostock 12
Testing effectiveness (Phase 2)Looking for participantsNCT05508009
What this trial is testing

Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor

Who this might be right for
SIODCystinosisFSGS+2 more
Alice Bertaina 12
Testing effectiveness (Phase 2)Study completedNCT00309257
What this trial is testing

Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome

Who this might be right for
Alport Syndrome
Mario Negri Institute for Pharmacological Research 9
Testing effectiveness (Phase 2)Looking for participantsNCT07523581
What this trial is testing

EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety

Who this might be right for
Alport Syndrome, X-LinkedAlport Syndrome, Autosomal Recessive
Eloxx Pharmaceuticals, Inc. 24
Not applicableStudy completedNCT03836144
What this trial is testing

Effect of Urine Alkalinazation on Urinary Inflammatory Markers in Patients With Cystinuria

Who this might be right for
CystinuriaRenal LithiasisGlomerulonephritis+1 more
European Georges Pompidou Hospital 63
Testing effectiveness (Phase 2)Study completedNCT05267262
What this trial is testing

Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis

Who this might be right for
Alport SyndromeFocal Segmental Glomerulosclerosis
River 3 Renal Corp. 43
Testing effectiveness (Phase 2)Ended earlyNCT02855268
What this trial is testing

Study of Lademirsen (SAR339375) in Patients With Alport Syndrome

Who this might be right for
Alport Syndrome
Genzyme, a Sanofi Company 43
Not applicableStudy completedNCT02555059
What this trial is testing

Special Drug Use Investigation of Ciproxan Injection in Pediatrics

Who this might be right for
Cystitis / Pyelonephritis / Cystic Fibrosis / Anthrax
Bayer 48
Next Page